Anaplasma phagocytophilum Ab (IgG) testing is a serological method used to detect antibodies, specifically Immunoglobulin G (IgG), against Anaplasma phagocytophilum, the bacterium responsible for the tick-borne disease known as anaplasmosis. The presence of IgG antibodies typically indicates past exposure or a more chronic immune response to this pathogen. IgG antibodies against A. phagocytophilum usually develop a few weeks after the initial infection and can persist in the bloodstream for a prolonged period, making them useful markers for past infection.
This test is particularly valuable in diagnosing patients with a history of tick exposure who present with symptoms consistent with anaplasmosis, such as fever, headache, muscle pain, and sometimes more severe manifestations like thrombocytopenia and leukopenia. A positive IgG test result suggests that the patient has been exposed to A. phagocytophilum, but it's important to note that it does not necessarily indicate an active infection, as IgG antibodies can remain long after the initial exposure has resolved.
For this reason, the interpretation of A. phagocytophilum IgG results should be done in conjunction with a thorough evaluation of the patient's clinical history, symptomatology, and other laboratory findings. In some cases, additional testing, such as polymerase chain reaction (PCR) or testing for IgM antibodies, which are produced earlier in the infection, may be necessary to confirm a current infection. Clinicians often use the results of the A. phagocytophilum Ab (IgG) test in combination with other diagnostic information to accurately diagnose and manage cases of anaplasmosis.
A. Phagocytophilum Ab (IgG)
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.